Heidi Elsaesser

3.8k total citations · 2 hit papers
24 papers, 2.8k citations indexed

About

Heidi Elsaesser is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Heidi Elsaesser has authored 24 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Heidi Elsaesser's work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (15 papers) and Immunotherapy and Immune Responses (9 papers). Heidi Elsaesser is often cited by papers focused on Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (15 papers) and Immunotherapy and Immune Responses (9 papers). Heidi Elsaesser collaborates with scholars based in United States, Canada and Norway. Heidi Elsaesser's co-authors include David G. Brooks, Elizabeth Wilson, Karsten Sauer, Douglas H. Yamada, Michael B. A. Oldstone, Dorian B. McGavern, Christopher L. Karp, Jonathan Herskovitz, Genhong Cheng and Jane C. Deng and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Heidi Elsaesser

23 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

2013 548 citations Elizabeth Wilson, Douglas H. Yamada et al. Science profile →
Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity

2013 419 citations Yoko Kidani, Heidi Elsaesser et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi Elsaesser United States	18	2.2k	680	499	476	277	24	2.8k
Surojit Sarkar United States	23	2.9k 1.3×	1.0k 1.5×	545 1.1×	480 1.0×	258 0.9×	47	3.7k
Lilin Ye China	27	1.9k 0.9×	488 0.7×	864 1.7×	510 1.1×	268 1.0×	80	2.9k
Elissa K. Deenick Australia	27	2.7k 1.3×	562 0.8×	498 1.0×	288 0.6×	201 0.7×	39	3.4k
Francesca Di Rosa Italy	21	3.2k 1.5×	890 1.3×	626 1.3×	343 0.7×	135 0.5×	45	3.9k
Shahram Salek‐Ardakani United States	37	2.8k 1.3×	1.1k 1.6×	848 1.7×	463 1.0×	185 0.7×	70	3.9k
Joyce T. Tan United States	15	4.6k 2.1×	993 1.5×	448 0.9×	548 1.2×	198 0.7×	20	5.0k
Takeo Nakaya Japan	11	1.6k 0.7×	712 1.0×	691 1.4×	416 0.9×	307 1.1×	30	2.3k
Simon Preston Australia	19	1.3k 0.6×	504 0.7×	737 1.5×	350 0.7×	186 0.7×	31	2.1k
Patrick Schaerli Switzerland	20	3.3k 1.5×	1.0k 1.5×	798 1.6×	324 0.7×	183 0.7×	21	4.5k
Mathias G. Lichtenheld United States	30	2.3k 1.1×	618 0.9×	836 1.7×	313 0.7×	159 0.6×	41	3.3k

Countries citing papers authored by Heidi Elsaesser

Since Specialization

Citations

This map shows the geographic impact of Heidi Elsaesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Elsaesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Elsaesser more than expected).

Fields of papers citing papers by Heidi Elsaesser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Elsaesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Elsaesser. The network helps show where Heidi Elsaesser may publish in the future.

Co-authorship network of co-authors of Heidi Elsaesser

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Elsaesser. A scholar is included among the top collaborators of Heidi Elsaesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Elsaesser. Heidi Elsaesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abd-Rabbo, Diala, Heidi Elsaesser, Vinicius Kannen, et al.. (2025). Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans. Cell Reports. 44(7). 115933–115933. 2 indexed citations

Guo, Mengdi, Diala Abd-Rabbo, Sabelo Lukhele, et al.. (2023). Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control. Cell Reports. 42(9). 113047–113047. 8 indexed citations

Lukhele, Sabelo, Mengdi Guo, Jian Shen, et al.. (2022). The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity. Immunity. 55(12). 2369–2385.e10. 67 indexed citations

Snell, Laura M., Wenxi Xu, Diala Abd-Rabbo, et al.. (2021). Dynamic CD4+ T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection. Nature Immunology. 22(12). 1524–1537. 28 indexed citations

MacLeod, Bethany, Heidi Elsaesser, Laura M. Snell, et al.. (2020). A network of immune and microbial modifications underlies viral persistence in the gastrointestinal tract. The Journal of Experimental Medicine. 217(12). 8 indexed citations

Gadalla, Ramy, Babak Noamani, Bethany MacLeod, et al.. (2019). Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials. Frontiers in Oncology. 9. 415–415. 110 indexed citations

Woo, Jin Seok, Sonal Srikanth, Kyun‐Do Kim, et al.. (2018). CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. The Journal of Immunology. 201(4). 1174–1185. 17 indexed citations

Snell, Laura M., Bethany MacLeod, Ivan Osokine, et al.. (2018). CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity. Immunity. 49(4). 678–694.e5. 86 indexed citations

Nagaoka, Yoshiko, Jing Wen, Heidi Elsaesser, et al.. (2017). Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming. AIDS Research and Human Retroviruses. 33(S1). S–59. 1 indexed citations

10.

Cunningham, Cameron R., Ameya S. Champhekar, Michael V. Tullius, et al.. (2016). Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. PLoS Pathogens. 12(1). e1005356–e1005356. 54 indexed citations

11.

Snell, Laura M., et al.. (2016). Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection. Cell Reports. 16(12). 3286–3296. 72 indexed citations

12.

Yamada, Douglas H., Heidi Elsaesser, Anja Lux, et al.. (2015). Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection. Immunity. 42(2). 379–390. 51 indexed citations

13.

Osokine, Ivan, Laura M. Snell, Cameron R. Cunningham, et al.. (2014). Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection. Proceedings of the National Academy of Sciences. 111(20). 7409–7414. 84 indexed citations

14.

Wilson, Elizabeth, Douglas H. Yamada, Heidi Elsaesser, et al.. (2013). Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection. Science. 340(6129). 202–207. 548 indexed citations breakdown →

15.

Balaji, Kavitha, Daniel L. Clemens, Gang Deng, et al.. (2013). Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proceedings of the National Academy of Sciences. 110(50). E4904–12. 71 indexed citations

16.

Kidani, Yoko, Heidi Elsaesser, M. Benjamin Hock, et al.. (2013). Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nature Immunology. 14(5). 489–499. 419 indexed citations breakdown →

17.

Wilson, Elizabeth, Yoko Kidani, Heidi Elsaesser, et al.. (2012). Emergence of Distinct Multiarmed Immunoregulatory Antigen-Presenting Cells during Persistent Viral Infection. Cell Host & Microbe. 11(5). 481–491. 47 indexed citations

18.

Fahey, Laura, et al.. (2011). Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. The Journal of Experimental Medicine. 208(5). 987–999. 260 indexed citations

19.

Elsaesser, Heidi, Karsten Sauer, & David G. Brooks. (2009). IL-21 Is Required to Control Chronic Viral Infection. Science. 324(5934). 1569–1572. 445 indexed citations

20.

Brooks, David G., Sang‐Jun Ha, Heidi Elsaesser, et al.. (2008). IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proceedings of the National Academy of Sciences. 105(51). 20428–20433. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact